ESOP28 Oct 2026, 08:01 pm
Aarti Pharmalabs Approves 850 Stock Options Under PSOP 2023
AI Summary
Aarti Pharmalabs Ltd announced that its Nomination and Remuneration Committee has approved the grant of 850 stock options to eligible employees under the APL Performance Stock Option Plan 2023 (PSOP 2023). The exercise price for these options is set at Rs. 5 per option. This move is in compliance with SEBI regulations regarding share-based employee benefits.
Key Highlights
- 850 stock options granted to employees.
- Under the APL Performance Stock Option Plan 2023.
- Exercise price set at Rs. 5 per option.
- Approved by the Nomination and Remuneration Committee.
Price Impact
More from AARTIPHARM